{
    "id": 2116,
    "fullName": "JAK1 Y1035C",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "JAK1 Y1035C lies within the protein kinase domain 2 of the Jak1 protein (UniProt.org). Y1035C results in constitutive Jak1 activation, increased phosphorylation of Stat5 and Erk, and is transforming in cell culture (PMID: 21393331, PMID: 20868368).",
            "references": [
                {
                    "id": 6165,
                    "pubMedId": 20868368,
                    "title": "Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-\u03b3.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20868368"
                },
                {
                    "id": 908,
                    "pubMedId": 21393331,
                    "title": "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21393331"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3716,
        "geneSymbol": "JAK1",
        "terms": [
            "JAK1",
            "JAK1A",
            "JAK1B",
            "JTK3"
        ]
    },
    "variant": "Y1035C",
    "createDate": "10/07/2014",
    "updateDate": "10/23/2019",
    "referenceTranscriptCoordinates": {
        "id": 104371,
        "transcript": "NM_002227",
        "gDna": "chr1:g.64837968T>C",
        "cDna": "c.3104A>G",
        "protein": "p.Y1035C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1207,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells harboring JAK1 Y1035C were sensitive to ATP-competetive JAK inhibitors, such as Jakafi (Ruxolitinib) (PMID: 21393331).",
            "molecularProfile": {
                "id": 2062,
                "profileName": "JAK1 Y1035C"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 908,
                    "pubMedId": 21393331,
                    "title": "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21393331"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2062,
            "profileName": "JAK1 Y1035C",
            "profileTreatmentApproaches": [
                {
                    "id": 5142,
                    "name": "JAK1 Inhibitor - ATP competitive",
                    "profileName": "JAK1 Y1035C"
                },
                {
                    "id": 5139,
                    "name": "JAK Inhibitor (Pan)",
                    "profileName": "JAK1 Y1035C"
                },
                {
                    "id": 5140,
                    "name": "JAK Inhibitor (Pan) - ATP competitive",
                    "profileName": "JAK1 Y1035C"
                },
                {
                    "id": 5141,
                    "name": "JAK1 Inhibitor",
                    "profileName": "JAK1 Y1035C"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 104371,
            "transcript": "NM_002227",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104366,
            "transcript": "NM_001321852",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104372,
            "transcript": "NM_001321855",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104368,
            "transcript": "NM_001321853",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104369,
            "transcript": "NM_001321856",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104367,
            "transcript": "NM_001321854",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 104370,
            "transcript": "NM_001320923",
            "gDna": "chr1:g.64837968T>C",
            "cDna": "c.3104A>G",
            "protein": "p.Y1035C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}